Evaluation of CD44+/CD24- and Aldehyde Dehydrogenase Enzyme Markers in Cancer Stem Cells as Prognostic Indicators for Triple-Negative Breast Cancer - Cureus

Triple-negative breast cancer (TNBC) has been extensively studied not just for its aggressive behavior but also to understand its complex molecular nature. This type of heterogeneous tumor shows no expression of estrogen receptor (ER) or progesterone receptor…

The World Health Organization (WHO) declared in 2020 that 2.3 million women were diagnosed with breast cancer with 685,000 deaths globally. As of the end of 2020, there were 7.8 million women alive w… [+19046 chars]

full article...